Qatar Petrochemical Selects Shaw for Expansion of 720 KTA Ethylene Plant

The Shaw Group Inc. (NYSE: SHAW) today announced it has been awarded a contract by Qatar Petrochemical Company Ltd. Q.S.C. (QAPCO) to provide basic engineering services for the expansion of a 720 KTA ethylene plant in Mesaieed, Qatar.

The project will provide the design needed for expanding the plant’s capacity by up to 25 percent.

“Shaw has provided services to QAPCO at this plant for nearly ten years. Most significantly, in 2002, we provided our proprietary technology and engineering for a successful, significant capacity expansion,” said Lou Pucher, president of Shaw’s Energy & Chemicals Group. “Our long relationship and experience puts Shaw in a unique position to best serve QAPCO in this new expansion endeavor.”

The undisclosed value of the basic engineering services contract will be included in Shaw's Energy & Chemicals segment's backlog of unfilled orders in the second quarter of fiscal year 2011.

An established leader in ethylene technology, Shaw has provided technology, design, engineering and/or construction for more than 120 plants. Current projects underway around the world include the following:

  • In India, Shaw is providing proprietary technology and basic engineering for a new 450,000 tons per annum ethylene plant for GAIL (India) Limited.
  • In Turkey, Shaw is providing engineering and procurement services for an ethylene plant capacity expansion of approximately 10 percent for Petkim Petrochemical Holding AS.
  • In Singapore, Shaw is providing technology, engineering, procurement and construction services for a 1,000 KTA olefins recovery facility and a 220 megawatt power cogeneration unit for ExxonMobil Chemical.

In 2010, Shaw announced full commercial operation of a grassroots 1,320 KTA ethylene plant in Al-Jubail, Saudi Arabia, for Eastern Petrochemical Company (SHARQ).

Source: http://www.shawgrp.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.